Study of ONO-1078 in Patients With Chronic Sinusitis

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To determine the efficacy and safety of ONO-1078 in patients with chronic sinusitis in a double-blind, randomized, placebo-controlled, parallel group, multi-center study

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ono Pharmaceutical Co. Ltd
• Treatments: Pranlukast

Criteria

Inclusion Criteria:

• chronic sinusitis

Exclusion Criteria:

• acute sinusitis

• chronic sinusitis with acute exacerbation